University of Texas Southwestern Medical Center

University of Texas Southwestern Medical Center is a medical facility located in Dallas, Texas. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Depression, Heart Failure and other specialties. University of Texas Southwestern Medical Center is involved with conducting 2,260 clinical trials across 2,059 conditions. There are 223 research doctors associated with this hospital, such as David Miller, MD, Matthew Campbell, MD, Syed M. Kazmi, and Patrick Leavey, MD.

The University of Texas Southwestern Medical Center is situated at 5323 Harry Hines Blvd, Dallas, Texas, United States. For access, use I-35E N, exit at Medical District Drive, and proceed west towards Harry Hines Blvd; the center is located on the left side.

**University of Texas Southwestern Medical Center - Financial Assistance and Contact Information** - **Financial Assistance Department:** For assistance, call 469-291-2000 or toll-free at 866-648-2455, Monday through Friday, 8:00 a.m. to 5:00 p.m. Mail completed applications and required documentation to FinancialAssistance@UT Southwestern Medical Center (Mail Code 9233), P.O. Box 36423, Dallas, Texas 75235-9662. - **Billing and Insurance Questions:** Contact the Account Resolutions Department at 469-291-2000 or toll-free at 866-648-2455, online via MyChart, or by mail at P.O. Box 848009, Dallas, TX 75284-8009. - **General Information:** Call 214-648-3111 or write to UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390.

The University of Texas Southwestern Medical Center accepts a wide range of major medical insurance plans. These include, but are not limited to, Aetna, Blue Cross Blue Shield Texas, Humana, UnitedHealthcare, and Wellcare. For a detailed list of specific insurance plans accepted, particularly by UT Physicians, patients are advised to verify their coverage directly with the clinical practice or hospital.

The University of Texas Southwestern Medical Center, located in Dallas, Texas, is ranked as the #1 hospital in Texas (tie) and among the top 20 in the nation for 2023-24 by U.S. News & World Report, with 11 of its specialties recognized in the top 50 nationally. It has earned accolades for diversity and inclusion, being named a Top LGBTQ+ Friendly Company and a Top Healthcare Company by notable publications. The center's research programs, funded by approximately $554.4 million annually, have made significant contributions, including the development of statin drugs and the discovery of gene variants affecting LDL cholesterol levels in the Dallas Heart Study.